Conversely, treatment with shikonin was shown to trigger ferroptosis by inducing heme oxygenase 1 (HMOX1) expression, thereby sensitizing ovarian cancer cells to cisplatin [43]. Here, HMOX1 is linked to ovarian carcinoma.